Loading…
avatar for Ilan Irony

Ilan Irony

FDA
Deputy Director, DCEPT, OTAT, CBER
After training at UCSF and NIH and years of practice in Internal Medicine and Endocrinology, Dr. Irony joined FDA CBER in 2000 as a clinical reviewer. He also worked in the Endocrine Division in CDER as a reviewer and team leader. In 2011, he returned to CBER first as branch chief, and then became Deputy Director in the Division of Clinical Evaluation and Pharmacology / Toxicology in the Office of Tissues and Advanced Therapies. In 2018 he was detailed as director of the Office of Orphan Products Development.

My Speakers Sessions

Wednesday, June 26
 

2:00pm